Benzinga | May 5, 2021 04:29PM EDT

Vanda Pharmaceuticals Q1 EPS $0.15, Inline, Sales $62.70M Miss $68.50M Estimate; Sees FY21 Sales $270M-$300M vs $283.4M Est.

Vanda Pharmaceuticals (NASDAQ:VNDA) reported quarterly earnings of $0.15 per share which met the analyst consensus estimate. This is a 1400 percent increase over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $62.70 million which missed the analyst consensus estimate of $68.50 million by 8.47 percent. This is a 8.10 percent increase over sales of $58.00 million the same period last year.